What to watch with tTG IgA and Wechseljahre?

The combination of tTG IgA (a marker for celiac disease) and menopause (Wechseljahre) is clinically relevant, but evidence for specific interactions is limited. tTG IgA is used for diagnosing and monitoring celiac disease. During menopause, hormonal changes (declining estrogen) can affect gut microbiota, intestinal permeability, and immune regulation. This could theoretically modulate tTG IgA levels or celiac symptoms, but robust studies are lacking. Additionally, menopausal symptoms like bloating, fatigue, or joint pain can mimic celiac disease. An increase in tTG IgA during menopause should not automatically be interpreted as worsening celiac disease; other causes (e.g., thyroid changes, iron deficiency) should be considered. The evidence is mostly mechanistic and observational, not from randomized trials. Recommendation: For known celiac patients in menopause, regular tTG IgA monitoring is reasonable, but always in the context of overall symptoms and possibly with duodenal biopsy confirmation. For new-onset symptoms (e.g., unexplained GI issues), tTG IgA testing is appropriate, but menopause should be considered a potential confounder. Evidence grade: human-moderate (observational studies, expert opinion).